Detalhe da pesquisa
1.
[Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy].
Rinsho Ketsueki
; 64(3): 198-202, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-37019673
2.
[Clinical features of five cases of acquired factor V deficiency].
Rinsho Ketsueki
; 63(7): 733-739, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35922940
3.
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival.
Br J Haematol
; 195(2): 217-229, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34318926
4.
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma.
Ann Hematol
; 99(5): 1063-1072, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32248251
5.
Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.
Cancer Sci
; 110(9): 2924-2932, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31336012
6.
Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma.
Ann Hematol
; 98(7): 1703-1711, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31049648
7.
Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis.
Int J Clin Oncol
; 24(12): 1620-1628, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172332
8.
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.
Hematol Oncol
; 36(5): 792-800, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176173
9.
[Treatment strategy for relapsed or refractory myeloma according to the new Guidelines].
Rinsho Ketsueki
; 59(10): 2178-2188, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-30305524
10.
Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan.
Cancer Sci
; 108(3): 461-468, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28092421
11.
Multiple myeloma treatment - should be continued or not?
Br J Haematol
; 198(2): 223-224, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468218
12.
Frequent bleeding symptoms associated with autoimmune acquired factor XIII/13 deficiency due to anti-factor XIII A and B subunit antibodies.
Am J Hematol
; 97(11): 1497-1500, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35957554
13.
Treatment algorithms for multiple myeloma in Japan.
Rinsho Ketsueki
; 58(8): 1014-1023, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28883264
14.
[Azacitidine treatment for acute myeloid leukemia with myelodysplasia-related changes during peritoneal dialysis].
Rinsho Ketsueki
; 58(12): 2369-2374, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-29332868
15.
Hematopoietic neoplasms accompanied by severe enterocolitis due to Aeromonas species.
Rinsho Ketsueki
; 58(4): 303-308, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28484157
16.
[Analysis of long-term survivors with cardiac AL amyloidosis].
Rinsho Ketsueki
; 58(11): 2197-2204, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-29212969
17.
A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma.
Br J Haematol
; 172(5): 745-56, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26732066
18.
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902).
Ann Hematol
; 95(6): 921-9, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044390
19.
Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma.
Acta Haematol
; 135(2): 113-21, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26505781
20.
Diffuse large B-cell lymphoma recurring with zosteriform cutaneous lesions.
Rinsho Ketsueki
; 57(5): 602-7, 2016 05.
Artigo
em Japonês
| MEDLINE | ID: mdl-27263785